INDEPENDENT NEWS

AFT Pharmaceuticals completes first deal in South America

Published: Thu 20 Jun 2019 02:00 PM
Market and Media release 20 June 2019
AFT Pharmaceuticals’ completes first deal in South America
AFT signs Maxigesic® Licensing Agreement with Barcelona-based Galenicum Vitae S.L.U for Colombia, Peru and Chile.
AFT Pharmaceuticals today announces it has established a beachhead in South America after signing a licensing agreement with Galenicum Vitae.
Galenicum is a Barcelona-based pharmaceutical company with offices across South America and around the globe. It plans to market, sell and distribute AFT’s patented combination analgesic, Maxigesic®, in Colombia, Peru and Chile. Products covered by the new agreement include tablets and oral liquid for paediatric use.
AFT Managing Director, Dr Hartley Atkinson, says: “We are pleased to be making progress on licensing agreements in Latin America. These agreements will be a welcome addition to the Central American markets already licensed, with sales now underway - or due to start – in the current financial year in El Salvador, Guatemala, Honduras, Costa Rica and Nicaragua.”
Dr Atkinson said AFT expects registration approvals in the territories covered by the Galenicum agreement to occur prior to the end of 2021 with sales occurring in the following year.
Galenicum Vitae’s CEO, Sergio Malagrida, said: “For us, including a product such us Maxigesic® in our portfolio represents a great opportunity to provide an innovative product reinforcing our market offering. We believe that this will be the initial launch of a future greater line of products”.
Peru, Colombia and Chile have a combined population of almost 100 million people and the combined retail current value of the over-the-counter pain relief market is NZ$749 million [Euromonitor, 2018.].
Maxigesic® is a patented, fixed ratio of ibuprofen for anti-inflammation management and paracetamol (also called acetaminophen) for pain management.

Next in Business, Science, and Tech

Competitiveness and transparency in the retail fuel market
By: New Zealand Government
A safer banking system for all New Zealanders
By: Reserve Bank
Christchurch plan to be NZ's aerospace testbed by 2025
By: Christchurch NZ
Abatement Notice served on Tamarind Taranaki Limited
By: Environmental Protection Authority
Changes recommended for winter grazing practices
By: New Zealand Government
Study recommends changes to benefit competion
By: Commerce Commission
Process concerns in market study
By: BusinessNZ
“At last!” says MTA in response to fuel market findings
By: Motor Trade Association
Reserve Bank decision will further slow nomy
By: New Zealand National Party
Banking industry welcomes conclusion to RBNZ capital review
By: NZ Bankers' Association
RBNZ's flawed bank capital process should be suspended
By: The New Zealand Initiative
Further consultation essential on bank capital proposals
By: BusinessNZ
Takinf full advantage of space
By: SpaceBase
Southland student set on satellite success
By: Great South
NZ First Welcomes Commitment to Improving Animal Welfare
By: New Zealand First Party
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media